Riley Myers

Riley Myers is Chief of the Office of Pharmaceutical Quality’s Advanced Pharmaceutical Manufacturing Laboratory in the Office of Testing and Research and a member of the Emerging Technology Team. Dr. Myers is also a member of the Framework for Regulatory Advanced Manufacturing Evaluation (FRAME) working group where he is evaluating approaches for regulating future distributed manufacturing technologies. He was previously a Lead Biologist in the Office of Biotechnology Products where he led a team responsible for the quality assessment of BLAs for therapeutic proteins. Before joining FDA, Dr. Myers studied mechanisms to programanti-pathogenic immune responses at Boston Children’s Hospital. Dr. Myers received his Ph.D. in immunology from the University of Alabama at Birmingham.